Fact CheckerSign in

NCT07009483Completed

Effectiveness of Psychodermatologic Educational Modules on Atopic Dermatitis Patient Outcomes

Source: ClinicalTrials.gov · Last updated 23 Sept 2026

Brief summary (registry, in English)

In a previous part of this study, we created educational modules about the psychodermatology of inflammatory skin conditions, with a particular emphasis on atopic dermatitis, for patients. These modules will empower patients to better manage both the psychological and physical aspects of their skin conditions. As part of this project, we aim to conduct a clinical trial to determine the effectiveness of these modules on eczema severity and health-related quality of life in patients. We hope to use these findings to develop and disseminate accessible educational material on the psychological aspects of dermatologic care.

Status (registry)
Completed
Study type
Interventional
Enrollment
57 (actual)
First submitted
29 May 2025
Start date
Jun 2025
Primary completion date
Jul 2025
Lead sponsor
University of Alberta
NCT number
NCT07009483

What you commit to

  • Study type: Interventional
  • Participants enrolled: 57
  • From Jun 2025 to the primary completion date, Jul 2025
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Does not have a new diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.

Age

  • Less than 4 years of age.

Other

  • Unable to access and/or navigate e-modules with reasonable support/instruction.
  • Unable to speak English at a level required to understand the content of this study.
  • Unable to provide informed consent.

Who the study is looking for

  • New diagnosis or follow-up for previous diagnosis of Atopic Dermatitis.
  • Reliable internet access to be able to access the e-modules.
  • Able to speak English at a level required to understand the content of this study.
  • Child participants will be included in this study contingent on the consent of their guardian/caregiver(s).
  • Age range of eligible participants: Age 4 years and older.

Age in the registry: 4 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Stollery Children'S Hospital
Coordinator of this site? Confirm its status
EdmontonCanadaUnknown status
Kaye Edmonton Clinic
Coordinator of this site? Confirm its status
EdmontonCanadaUnknown status
Rao Dermatology
Coordinator of this site? Confirm its status
EdmontonCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.